EDGAR Filing Documents for 0001279569-09-001229

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001279569-09-001229

Filing Date

2009-10-06

Accepted

2009-10-06 15:43:29

Documents

Period of Report

2009-08-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	lorus6k.htm	6-K	15203
2	NEWS RELEASE DATED OCTOBER 6, 2009	ex991.htm	EX-99.1	64805
3	Q1 INTERIM FINANCIAL STATEMENTS	ex992.htm	EX-99.2	422947
4	Q1 MANAGEMENT DISCUSSION AND ANALYSIS	ex993.htm	EX-99.3	192312
5	CEO AND CFO CERTIFICATIONS	ex994.htm	EX-99.4	34189
6	LORUS THERAPEUTICS LOGO	lorus.jpg	GRAPHIC	11681
	Complete submission text file	0001279569-09-001229.txt		747333

Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7

Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7

LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 091107977
SIC: 2836 Biological Products, (No Diagnostic Substances)